Literature DB >> 3920503

Differential expression of multiple forms of arginase in cultured cells.

E B Spector, R M Kern, D F Haggerty, S D Cederbaum.   

Abstract

Arginase (EC 3.5.3.1), the final enzyme in the urea cycle, catalyzes the cleavage of arginine to orthinine and urea. At least two forms of this enzyme, AI and AII, have been described and are probably encoded by discrete genetic loci. The expression of these separate genes has been studied in mammalian cells grown in culture. The permanent rat-hepatoma line H4-II-E-C3 contained exclusively the AI enzyme; the form in mammals comprising about 98% of the arginase activity in liver and erythrocytes but catalyzing only about one half of that reaction in kidney, gastrointestinal tract, and brain. By contrast, human-embryonic-kidney and -brain cells, after transformation with the human papovavirus BK, contained only the AII species of arginase, which form contributes the remaining half of that catalysis in those mammalian tissues in vivo. We report here the results of an extensive study on the properties of these two forms of arginase in the three cell lines, including Km values for arginine, behavior on polyacrylamide gels under non-denaturing conditions, and cross-reactivity with lapine antibodies against the arginases from either rat or human liver.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3920503     DOI: 10.1007/bf00231822

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  28 in total

1.  Transformation of human embryonic kidney cells by human papovarirus BK.

Authors:  A F Purchio; G C Fareed
Journal:  J Virol       Date:  1979-02       Impact factor: 5.103

2.  Types of arginase in rat tissues.

Authors:  P K Reddi; W E Knox; A Herzfeld
Journal:  Enzyme       Date:  1975

3.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

4.  Statistical considerations in the estimation of enzyme kinetic parameters by the direct linear plot andother methods.

Authors:  A Cornish-Bowden; R Eisenthal
Journal:  Biochem J       Date:  1974-06       Impact factor: 3.857

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Argininemia treated from birth.

Authors:  S E Snyderman; C Sansaricq; P M Norton; F Goldstein
Journal:  J Pediatr       Date:  1979-07       Impact factor: 4.406

7.  Hyperargininemia with arginase deficiency.

Authors:  S D Cederbaum; K N Shaw; E B Spector; M A Verity; P J Snodgrass; G I Sugarman
Journal:  Pediatr Res       Date:  1979-07       Impact factor: 3.756

8.  Hyperargininemia.

Authors:  S D Cederbaum; K N Shaw; M Valente
Journal:  J Pediatr       Date:  1977-04       Impact factor: 4.406

9.  Argininemia.

Authors:  S E Snyderman; C Sansaricq; W J Chen; P M Norton; S V Phansalkar
Journal:  J Pediatr       Date:  1977-04       Impact factor: 4.406

10.  Studies of renal urea cycle enzymes. I. Renal concentrating ability and urea cycle enzymes in the rat during protein deprivation.

Authors:  A Aperia; O Broberger; A Larsson; K Snellman
Journal:  Scand J Clin Lab Invest       Date:  1979-06       Impact factor: 1.713

View more
  3 in total

1.  Differential expression of the two human arginase genes in hyperargininemia. Enzymatic, pathologic, and molecular analysis.

Authors:  W W Grody; C Argyle; R M Kern; G J Dizikes; E B Spector; A D Strickland; D Klein; S D Cederbaum
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

2.  Purification of a multipotent antideath activity from bovine liver and its identification as arginase: nitric oxide-independent inhibition of neuronal apoptosis.

Authors:  F Esch; K I Lin; A Hills; K Zaman; J M Baraban; S Chatterjee; L Rubin; D E Ash; R R Ratan
Journal:  J Neurosci       Date:  1998-06-01       Impact factor: 6.167

3.  Short-term correction of arginase deficiency in a neonatal murine model with a helper-dependent adenoviral vector.

Authors:  Chia-Ling Gau; Robin A Rosenblatt; Vincenzo Cerullo; Fides D Lay; Adrienne C Dow; Justin Livesay; Nicola Brunetti-Pierri; Brendan Lee; Stephen D Cederbaum; Wayne W Grody; Gerald S Lipshutz
Journal:  Mol Ther       Date:  2009-04-14       Impact factor: 11.454

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.